Dose Ranging Study of Rimegepant (BMS-927711) for the Acute Treatment of Migraine
Completed · Phase 2 · Has a placebo group
Conditions studied: Migraine, Acute Treatment of Migraine
In brief
The primary purpose of this study is to evaluate the efficacy of rimegepant (BMS-927711) compared with placebo in the acute treatment of migraine as measured by Pain Freedom (headache pain intensity level reported as "no pain") at 2 hours post dose using a four point numeric rating scale (no pain, mild pain, moderate pain, severe pain) while identifying an optimal dose to support the Phase 3 clinical trials.
Key facts
- Study ID
- NCT01430442
- Run by
- Pfizer
- People needed
- 1026
- Starts
- 2011-10-01
- Expected to finish
- 2012-05-01
- Last updated by the study team
- 2023-02-28
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Mayo Clinic Arizona — Scottsdale, Arizona, United States
- Clinical Res. Advantage Inc/ Desert Clinical Research Llc — Tempe, Arizona, United States
- University Of California, San Francisco — San Francisco, California, United States
- California Medical Clinic For Headache — Santa Monica, California, United States
- Encompass Clinical Research — Spring Valley, California, United States
- Diablo Clinical Research, Inc. — Walnut Creek, California, United States
- Radiant Research, Inc. — Denver, Colorado, United States
- Miami Research Associates — Miami, Florida, United States
- Renstar Medical Research — Ocala, Florida, United States
- Compass Research, Llc — Orlando, Florida, United States
- Broward Research Group — Pembroke Pines, Florida, United States
- Comprehensive Clinical Development, Inc — St. Petersburg, Florida, United States
- Diamond Headache Clinic, Ltd. — Chicago, Illinois, United States
- Milford Emergency Associates, Inc. — Milford, Massachusetts, United States
- Medvadis Research Corporation — Watertown, Massachusetts, United States
- Michigan Head Pain And Neurological Institute — Ann Arbor, Michigan, United States
- Clinical Research Institute, Inc. — Minneapolis, Minnesota, United States
- The Center For Pharmaceutical Research. Pc — Kansas City, Missouri, United States
- Clinvest/ A Division Of Banyan Group, Inc. — Springfield, Missouri, United States
- Mercy Health Research — St Louis, Missouri, United States
- Regional Clinical Research Inc. — Endwell, New York, United States
- Central New York Clinical Research — Manlius, New York, United States
- Rochester Clinical Research, Inc. — Rochester, New York, United States
- Pharmquest — Greensboro, North Carolina, United States
- Wake Research Associates — Raleigh, North Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.